Philips Image Guided Therapy System – Azurion – with Ambient Experience and FlexVision display helps reduce patient anxiety during interventional procedures
March 30 2022 - 9:00AM
March 30, 2022
- New solution for interventional rooms offers patients a calming
multi-sensory experience while staff prepare them for their
procedure
- Ambient Experience with FlexVision display aims to help
increases patient comfort, potentially improving interventional
procedure workflows, outcomes, and productivity
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced commercial availability of the company’s new solution for
interventional rooms, Ambient Experience with FlexVision display,
which will be showcased at the American College of Cardiology’s
71st Annual Scientific Session & Expo (ACC 2022), April 2-4,
Washington, D.C., USA. Connecting to Philips Image Guided Therapy
System - Azurion, it uses the system’s large display to offer
patients a calming multi-sensory experience while staff prepare
them for their procedure, prior to the display being used for the
actual intervention. It also allows patients and interventional
team members to adapt the room’s ambient lighting and sound to add
to the overall feeling of calm, especially during the patient entry
and preparation phases of procedures. Aimed at reducing patient
anxiety during interventional procedures, Ambient Experience,
leveraging FlexVision display, has the potential to improve the
patient and staff experience, positively impact outcomes, and
enhance workflows and productivity.
Anxiety in patients undergoing minimally-invasive image-guided
therapy typically peaks immediately before the procedure is
performed. As a result, sedative drugs and general anesthesia are
commonly used in interventional rooms to ensure patients lie still
during procedures. Mitigating the clinical atmosphere associated
with typical interventional rooms by introducing positive elements
that distract, inform, educate, and empower patients, Philips
Ambient Experience aims to reduce patient anxiety to a level where
interventionists can operate more productively and efficiently. For
example, the solution could reduce the overall procedure time and,
in some cases, reduce the costs associated with patient sedation or
general anesthesia [1].
“One factor in our decision to use Philips’ solution is that
along with the patient experience, it has been shown that you can
use less anesthesia in some cases due to the relaxing and
distracting factors of Ambient Experience. We wanted to set
ourselves apart from other labs,” said Victor Hall, Vice President
of the Heart and Vascular Institute, Baptist Health Care Pensacola,
Florida, US.
“Interventional procedures can be challenging for patients,
especially those who are anxious about the intervention and the
outcome,” said Werner Satter, General Manager Ambient Experience at
Philips. “With the addition of Ambient Experience connected to
FlexVision display, which is part of Philips Image Guided Therapy
System – Azurion, we address the atmosphere and mood of the room by
offering active relaxation opportunities for patients and
staff.”
In addition to the system’s library of pre-recorded themes,
Ambient Experience also connects to media devices such as mobile
phones and tablets, adding a powerful element of interactivity and
choice so that patients and staff can enjoy an even more
personalized experience. Single-touch control allows interventional
room staff to switch between customized presets and optimal
lighting and audio settings for each phase of a procedure.
Philips Ambient Experience applies evidence-based, human-focused
innovation and design thinking to give patients and staff an
engaging and pleasant experience, while also improving the
efficiency of diagnostic and therapeutic procedures and building
confidence in the services and reputation of healthcare facilities.
Reduced patient anxiety contributes to better patient and staff
experiences and potentially better patient outcomes, while improved
efficiency contributes to lower cost of care, helping healthcare
providers meet all four aspects of the Quadruple Aim.
Ambient Experience has a wide range of healthcare application
areas. In the radiology department of Noah’s Ark Children’s
Hospital for Wales (Cardiff, UK), where it provides an immersive
interactive experience for children from the moment they arrive, a
patient-satisfaction study showed that Philips Ambient Experience
achieved high net promoter scores [2].
Join Philips in person at ACC 2022 to discover the latest
innovations in cardiology from Philips.
[1] A fresh perspective from the interventional suite – research
paper, Philips 2021. [2] Results from case studies are not
predictive of results in other cases. Results in other cases may
vary.
For further information, please contact:
Joost Maltha Philips Global Press Office Tel:
+31 6 10 55
8116 Email: joost.maltha@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2021 sales of EUR 17.2 billion and
employs approximately 78,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips Ambient Experience and FlexVision display
- Philips Ambient Experience and FlexVision display for pediatric
patients
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Sep 2023 to Sep 2024